BP

Biostar Pharmaceuticals

BSPM
OTCHealth Care
$0.00
USD
+0.00(0.00%)
At close: Jun 16, 20:00 UTC

Open

Prev. Close

High

Low

Market Snapshot

Market Cap

$266.27

P/E Ratio

0.0

EPS

-0.10

Employees

200

About

BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The firm offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The firm's products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people. The firm's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.

Recently from Cashu